AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Control Bionics Ltd

0.037

-0.004-9.76%

Volume:815.28K

Turnover:31.16K

Market Cap:10.90M

PE:-1.18

High:0.040

Open:0.040

Low:0.037

Close:0.041

Loading ...

Overview Company News Filings

Control Bionics Raises AU$2 Million Via Private Placement

MT Newswires Live

BRIEF-Control Bionics Says Raised A$2.0 Mln Via Private Placement At A$0.045 Per Share

BUZZ-Australia's Control Bionics gains on premium placement

Control Bionics Ltd - Raised Approximately a$2.0 Mln via a Private Placement at an Issue Price of a$0.045 per Share

THOMSON REUTERS

Control Bionics' US Business Logs Record Revenue in Fiscal Q2

MT Newswires Live

Sector Update: Financial Stocks Decline Late Afternoon

MT Newswires Live

CBL & Associates Completes $34 Million Sale of Monroeville Mall

MT Newswires Live

CBL Properties Closes Acquisition of JV Partner's Stake in Three Mall Properties

MT Newswires Live

BRIEF-Control Bionics Says Roger Hawke Has Resigned As Chairman

Control Bionics Ltd - Roger Hawke Has Resigned as Chairman of CBL

THOMSON REUTERS

Control Bionics - Appointed Samuel Straface as Non-Executive Chairman

THOMSON REUTERS

BRIEF-Control Bionics Anticipates U.S. Revenue For 1H Will Exceed By More Than 15%

Control Bionics’ US sales and revenue growth fuels strong start to FY25

Control Bionics - Revenue in H2 of Calendar 2024 Expected to Be Almost 30% Higher Than First 6 Months of Cy2024

THOMSON REUTERS

Control Bionics Ltd - Anticipate US Revenue for 1H FY25 Will Exceed by More Than 15%

THOMSON REUTERS

BRIEF-Control Bionics ANnounces Expansion Into U.S. Sports And Japanese Rehab Markets

ASX Small-Cap Stocks to Watch

MT Newswires Live

Control Bionics inks new technology partnerships in US, Japan for sports and rehab

The Market Herald

ASX Alert-Expansion Into US Sports and Japanese Rehab Markets-CBL.ax

THOMSON REUTERS

Control Bionics Ltd-Issue of Underwriting Shares and Placement Shares

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CBL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","market":"AU","secType":"STK","nameCN":"Control Bionics Ltd","latestPrice":0.037,"timestamp":1745301613316,"preClose":0.041,"halted":0,"volume":815275,"delay":0,"nameEN":"Control Bionics Ltd","floatShares":114482928,"shares":294611102,"eps":-0.031267,"marketStatus":"Closed","change":-0.004,"latestTime":"04-22 16:00:13 AEST","open":0.04,"high":0.04,"low":0.037,"amount":31155,"amplitude":0.073171,"askPrice":0.037,"askSize":38427,"bidPrice":0.034,"bidSize":100000,"shortable":3,"etf":0,"ttmEps":-0.031267,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.041,"openAndCloseTimeList":[[1745280000000,1745301600000]],"volumeRatio":9.73372,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","floatShares":114482928,"roa":"-48.68%","roe":"-98.08%","lyrEps":-0.037101,"volumeRatio":9.73372,"shares":294611102,"dividePrice":0,"high":0.04,"amplitude":0.073171,"preClose":0.041,"low":0.037,"week52Low":0.034,"pbRate":"1.69","psRate":"2.06","week52High":0.105,"institutionHeld":0,"latestPrice":0.037,"committee":0.444805,"eps":-0.031267,"divideRate":0,"volume":815275,"delay":0,"ttmEps":-0.031267,"open":0.04,"prevYearClose":0.06,"prevWeekClose":0.041,"prevMonthClose":0.045,"prevQuarterClose":0.045,"fiveDayClose":0.046,"twentyDayClose":0.04,"sixtyDayClose":0.062},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514030839","title":"Control Bionics Raises AU$2 Million Via Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2514030839","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514030839?lang=en_us&edition=fundamental","pubTime":"2025-02-25 14:23","pubTimestamp":1740464592,"startTime":"0","endTime":"0","summary":"Control Bionics  raised around AU$2 million via a private placement to two existing shareholders, Nightingale Partners and Phoenix Development Fund, at an issue price of AU$0.045 per share, according to a Tuesday Australian bourse filing.A total of 4.8 million shares were issued under the firm's share issue capacity.It will use the proceeds to focus on revenue growth in its core operations and the expansion into new high-potential markets, including the NeuroNode Only and NeuroStrip platforms.The firm's shares rose 4% on market close Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBL.AU","BK7007"],"gpt_icon":0},{"id":"2514033921","title":"BRIEF-Control Bionics Says Raised A$2.0 Mln Via Private Placement At A$0.045 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2514033921","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514033921?lang=en_us&edition=fundamental","pubTime":"2025-02-25 11:31","pubTimestamp":1740454267,"startTime":"0","endTime":"0","summary":"BRIEF-Control Bionics Says Raised A$2.0 Mln Via Private Placement At A$0.045 Per ShareFeb 25 (Reuters) - Control Bionics Ltd CBL.AX:RAISED APPROXIMATELY A$2.0 MILLION VIA A PRIVATE PLACEMENT AT AN ISS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PF1Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"gpt_icon":0},{"id":"2514089508","title":"BUZZ-Australia's Control Bionics gains on premium placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2514089508","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514089508?lang=en_us&edition=fundamental","pubTime":"2025-02-25 09:21","pubTimestamp":1740446480,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Control Bionics gains on premium placement** Shares of Australia's Control Bionics CBL.AX rise as much as 4.8% to A$0.044, its highest level since February 17** The medical device manufacturer raises A$2.0 million   via private placement at an issue price of A$0.045 per share ** Issue price represents a premium of 7.1% to stock's last closing** Funds raised to help the company \"focus on revenue growth in its core operations and the expansion into new high-potential markets\" — CBL** Stock has fallen 26.7% this year, as of 0118 GMT  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3N3PG03U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"gpt_icon":0},{"id":"2514050097","title":"Control Bionics Ltd -  Raised Approximately a$2.0 Mln via a Private Placement at an Issue Price of a$0.045 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2514050097","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514050097?lang=en_us&edition=fundamental","pubTime":"2025-02-25 05:08","pubTimestamp":1740431307,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF1Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"gpt_icon":0},{"id":"2508169901","title":"Control Bionics' US Business Logs Record Revenue in Fiscal Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2508169901","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508169901?lang=en_us&edition=fundamental","pubTime":"2025-02-03 11:03","pubTimestamp":1738551832,"startTime":"0","endTime":"0","summary":"Control Bionics'  US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.The company said it is \"positioned for strong growth\" in the second half of the fiscal year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBL.AU"],"gpt_icon":0},{"id":"2508009992","title":"Sector Update: Financial Stocks Decline Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2508009992","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508009992?lang=en_us&edition=fundamental","pubTime":"2025-02-01 04:52","pubTimestamp":1738356749,"startTime":"0","endTime":"0","summary":"Financial stocks fell in late Friday afternoon trading, with the NYSE Financial Index down 0.7% and the Financial Select Sector SPDR Fund (XLF) decreasing 0.5%.The Philadelphia Housing Index dropped 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBL","GB00B4LPDJ14.GBP","LU1064131342.USD","LU0265550359.USD","SG9999018865.SGD","LU1712237335.SGD","LU1037948897.HKD","LU2087625088.SGD","SG9999014880.SGD","IE00BWXC8680.SGD","LU0672654240.SGD","LU2244417387.USD","BK4585","LU1633808545.USD","LU0965509010.AUD","LU0965509283.SGD","LU1316542783.SGD","XLF","DB","XLRE","LU1934455863.HKD","CBL.AU","LU0128525929.USD","LU0170899867.USD","LU2023250843.SGD","LU0861579265.USD","LU0426412945.USD","LU0942090050.USD","LU0289941410.SGD","BK4559","LU1121112475.USD","LU0234570918.USD","V","LU0061474960.USD","LU0354030438.USD","LU0823421416.USD","BK4534","LU0057025933.USD","LU2023251221.USD","LU0056508442.USD","LU1823568750.SGD","LU2264538146.SGD","WT","LU1988902786.USD","LU0158827781.USD","LU0545562505.USD","LU0006306889.USD","LU0048584097.USD","IE00B1XK9C88.USD","LU1046421795.USD"],"gpt_icon":1},{"id":"2508991382","title":"CBL & Associates Completes $34 Million Sale of Monroeville Mall","url":"https://stock-news.laohu8.com/highlight/detail?id=2508991382","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508991382?lang=en_us&edition=fundamental","pubTime":"2025-02-01 03:32","pubTimestamp":1738351926,"startTime":"0","endTime":"0","summary":"CBL & Associates Properties  on Friday said it completed the sale of Monroeville Mall and Annex in Monroeville, Pennsylvania, for $34 million in cash.The company said it used about $7.1 million to reduce the outstanding principal on its outparcel and open-air center loan to $333 million.Shares of the company were up nearly 4% in recent trading.Price: 30.53, Change: +1.07, Percent Change: +3.63","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBL","BK7007","BK4231","CBL.AU","BK4080"],"gpt_icon":0},{"id":"2493271916","title":"CBL Properties Closes Acquisition of JV Partner's Stake in Three Mall Properties","url":"https://stock-news.laohu8.com/highlight/detail?id=2493271916","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493271916?lang=en_us&edition=fundamental","pubTime":"2024-12-24 06:08","pubTimestamp":1734991708,"startTime":"0","endTime":"0","summary":"CBL Properties  closed the acquisition of its partner's 50% joint venture stakes in CoolSprings Galleria in Nashville, Oak Park Mall in Kansas City, Kansas, and West County Center in St. Louis.The stakes were bought for $22.5 million in cash and the assumption of $266.7 million in three nonrecourse loans, CBL said Monday in a statement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK4080","CBL","CBL.AU","BK4231"],"gpt_icon":0},{"id":"2492858819","title":"BRIEF-Control Bionics Says Roger Hawke Has Resigned As Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2492858819","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492858819?lang=en_us&edition=fundamental","pubTime":"2024-12-17 14:34","pubTimestamp":1734417243,"startTime":"0","endTime":"0","summary":"BRIEF-Control Bionics Says Roger Hawke Has Resigned As ChairmanDec 17 (Reuters) - Control Bionics CBL.AX:ROGER HAWKE HAS RESIGNED AS CHAIRMAN OF CBLAPPOINTED SAMUEL STRAFACE AS NON-EXECUTIVE CHAIRMANFurther company coverage: CBL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NH0ZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"gpt_icon":0},{"id":"2492983087","title":"Control Bionics Ltd - Roger Hawke Has Resigned as Chairman of CBL","url":"https://stock-news.laohu8.com/highlight/detail?id=2492983087","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492983087?lang=en_us&edition=fundamental","pubTime":"2024-12-17 14:30","pubTimestamp":1734417046,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NH0ZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"gpt_icon":0},{"id":"2492830809","title":"Control Bionics  - Appointed Samuel Straface as Non-Executive Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2492830809","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492830809?lang=en_us&edition=fundamental","pubTime":"2024-12-17 14:30","pubTimestamp":1734417046,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NH0ZQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"gpt_icon":0},{"id":"2492676712","title":"BRIEF-Control Bionics Anticipates U.S. Revenue For 1H Will Exceed By More Than 15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492676712","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492676712?lang=en_us&edition=fundamental","pubTime":"2024-12-17 09:11","pubTimestamp":1734397893,"startTime":"0","endTime":"0","summary":"Dec 17 (Reuters) - Control Bionics Ltd   :   * ANTICIPATE US REVENUE FOR 1H FY25 WILL EXCEED BY MORE THAN 15%   * REVENUE IN H2 OF CALENDAR 2024 EXPECTED TO BE ALMOST 30% HIGHER THAN FIRST 6 MONTHS OF CY2024Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU"],"gpt_icon":0},{"id":"2492162188","title":"Control Bionics’ US sales and revenue growth fuels strong start to FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2492162188","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492162188?lang=en_us&edition=fundamental","pubTime":"2024-12-17 06:34","pubTimestamp":1734388456,"startTime":"0","endTime":"0","summary":"Australian medical device company Control Bionics  is expecting US revenue for the first six months of the 2025 financial year to increase by more than 15% on the previous corresponding period.The anticipated performance reflects increasing demand for the company’s artificial intelligence-based solutions, growing market penetration and a new Healthcare Common Procedure Coding System code for US sales of the NeuroNode wireless wearable sensor.With December traditionally being Control’s strongest month for US sales, the company is expecting to end the year on a high with positive EBITDA from the region.Revenue for the last six months of the calendar year 2024 is forecast to be almost 30% higher than in the first half of the year.The company is anticipating increased sales after a new US academic customer placed a maiden order with Control’s US subsidiary.Control is currently finalising a deal with Cleveland Metro Health as its clinical trial partner in the US to help bring Drove towards ","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/12/Control-Bionics-ASX-CBL-1H-FY25-business-update.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2024/12/Control-Bionics-ASX-CBL-1H-FY25-business-update.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/control-bionics-us-sales-revenue-growth-fuels-strong-start-fy25/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["XAO.AU","XJO.AU","BK7007","CBL.AU","XKO.AU"],"gpt_icon":0},{"id":"2492483640","title":"Control Bionics - Revenue in H2 of Calendar 2024 Expected to Be Almost 30% Higher Than First 6 Months of Cy2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2492483640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492483640?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:14","pubTimestamp":1734383671,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH1EK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"gpt_icon":0},{"id":"2492401796","title":"Control Bionics Ltd -  Anticipate US Revenue for 1H FY25 Will Exceed by More Than 15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492401796","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492401796?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:14","pubTimestamp":1734383671,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH1EK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"gpt_icon":0},{"id":"2491105688","title":"BRIEF-Control Bionics ANnounces Expansion Into U.S. Sports And Japanese Rehab Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2491105688","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491105688?lang=en_us&edition=fundamental","pubTime":"2024-12-16 08:47","pubTimestamp":1734310031,"startTime":"0","endTime":"0","summary":"Dec 16 (Reuters) - Control Bionics Ltd   :   * EXPANSION INTO US SPORTS AND JAPANESE REHAB MARKETSFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"gpt_icon":0},{"id":"2491507695","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2491507695","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491507695?lang=en_us&edition=fundamental","pubTime":"2024-12-16 07:44","pubTimestamp":1734306272,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Great Western Exploration (ASX:GTE)Great Western Exploration suspended a downhole ele","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GTE.AU","XAO.AU","VIP.AU","BK7060","CBL.AU","FHS.AU","BK7007","BK7129","XKO.AU","BK7126","XJO.AU","CCE.AU","BK7095","BK7501"],"gpt_icon":0},{"id":"2491502536","title":"Control Bionics inks new technology partnerships in US, Japan for sports and rehab","url":"https://stock-news.laohu8.com/highlight/detail?id=2491502536","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491502536?lang=en_us&edition=fundamental","pubTime":"2024-12-16 07:11","pubTimestamp":1734304260,"startTime":"0","endTime":"0","summary":"Control Bionics Ltd  has formalised two strategic partnerships representing its move into the U.S. sports performance market and the Japanese neurological rehabilitation market respectively, cutting deals with market leaders for both.In the first case, CBL has acquired a 20% stake in Neuro Elite Athletics, the company responsible for NeuroBounce – a unique computerised electromyography training solution which enables an increase in vertical leap by five to 15 centimetres and enhances explosiveness in only eight sessions, with suitability for basketball, volleyball, and football athletes.NeuroBounce uses CBL’s technology exclusively, and the latter’s investment – which represents $250,0000 – is intended to speed up the rollout of this program across U.S. markets. The projected revenues for NeuroBounce are also promising, coming in at US$25,000 annually for each program.CBL has also entered a Memorandum of Understanding  with Stroke Lab, a Tokyo-based rehabilitation facility, to facilita","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/control-bionics-inks-new-technology-partnerships-in-us-japan-for-sports-and-rehab-2024-12-16/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7007","CBL.AU"],"gpt_icon":0},{"id":"2491150628","title":"ASX Alert-Expansion Into US Sports and Japanese Rehab Markets-CBL.ax","url":"https://stock-news.laohu8.com/highlight/detail?id=2491150628","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491150628?lang=en_us&edition=fundamental","pubTime":"2024-12-16 05:27","pubTimestamp":1734298055,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241215:nFWN3NF00C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"gpt_icon":0},{"id":"2475440566","title":"Control Bionics Ltd-Issue of Underwriting Shares and Placement Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2475440566","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475440566?lang=en_us&edition=fundamental","pubTime":"2024-10-16 08:56","pubTimestamp":1729040173,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241016:nTUE5V3STY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBL.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBL.AU\",market:\"AU\",,,undefined,":[]}}